Comparison of Patient Outcomes Before and After Switching From Warfarin to a Direct Oral Anticoagulant Based on Time in Therapeutic Range Guideline Recommendations.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 35834255.
- Also identified by DOI 10.1001/jamanetworkopen.2022.22089 and PMC identifier 9284330.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
This cohort study evaluates stroke and major bleeding rates before and after switching from warfarin to a direct oral anticoagulant (DOAC) in patients grouped by pre-switch time-in-therapeutic range guideline thresholds.
Medical subject headings
- Anticoagulants
- Warfarin